Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SHP1 agonists(protein tyrosine phosphatase non-receptor type 6 agonists), STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H15ClF3N3O2 |
InChIKeyZJHYNWKIDHLGTH-UHFFFAOYSA-N |
CAS Registry1400989-31-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | CN | 07 Feb 2013 |